Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $70,033 | 36 | 84.0% |
| Food and Beverage | $10,188 | 420 | 12.2% |
| Travel and Lodging | $3,162 | 9 | 3.8% |
| Gift | $25.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $46,275 | 163 | $0 (2024) |
| Daiichi Sankyo Inc. | $14,755 | 35 | $0 (2022) |
| Allergan Inc. | $11,042 | 31 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $3,455 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $2,719 | 3 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $689.49 | 6 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $462.87 | 25 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $433.15 | 36 | $0 (2022) |
| Medtronic, Inc. | $329.16 | 2 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $314.56 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $789.19 | 14 | Medtronic, Inc. ($329.16) |
| 2023 | $281.09 | 2 | CONMED Corporation ($281.09) |
| 2022 | $12,952 | 82 | ABBVIE INC. ($12,109) |
| 2021 | $4,178 | 45 | E.R. Squibb & Sons, L.L.C. ($3,455) |
| 2020 | $3,915 | 26 | AbbVie Inc. ($3,810) |
| 2019 | $10,809 | 46 | AbbVie, Inc. ($9,779) |
| 2018 | $8,914 | 104 | Allergan Inc. ($3,067) |
| 2017 | $41,568 | 147 | AbbVie, Inc. ($17,421) |
All Payment Transactions
466 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $185.89 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $102.08 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $143.27 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 02/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2023 | CONMED Corporation | CONMED GENERATORS (Device), CONMED HEMOSTASIS, CONMED BILIARY | Food and Beverage | In-kind items and services | $128.30 | General |
| Category: GENERAL SURGERY | ||||||
| 10/22/2023 | CONMED Corporation | CONMED BILIARY (Device) | Food and Beverage | In-kind items and services | $152.79 | General |
| Category: GENERAL SURGERY | ||||||
| 12/09/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Inflammation | ||||||
| 11/17/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: CRITICAL CARE | ||||||
| 11/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/03/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 11/01/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Immunology | ||||||
| 10/12/2022 | ABBVIE INC. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 209 | 211 | $88,562 | $25,050 |
| 2022 | 10 | 599 | 612 | $373,717 | $66,099 |
| 2021 | 15 | 780 | 802 | $448,597 | $84,821 |
| 2020 | 15 | 945 | 1,009 | $507,542 | $95,285 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $20,941 | $5,959 | 28.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 29 | 29 | $20,996 | $4,870 | 23.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $9,826 | $3,449 | 35.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 24 | 24 | $9,720 | $3,084 | 31.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $10,179 | $2,297 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 37 | 37 | $3,796 | $2,190 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $2,036 | $1,216 | 59.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $9,918 | $1,172 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 16 | $1,150 | $813.12 | 70.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 75 | 75 | $48,148 | $13,117 | 27.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 98 | 98 | $78,648 | $12,325 | 15.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 62 | 62 | $58,926 | $11,763 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 120 | $28,598 | $7,051 | 24.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $26,621 | $4,487 | 16.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $16,752 | $4,426 | 26.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 68 | 70 | $43,032 | $3,957 | 9.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 60 | 60 | $31,218 | $3,699 | 11.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 33 | 36 | $33,029 | $3,106 | 9.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $8,744 | $2,170 | 24.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 120 | 121 | $95,981 | $15,696 | 16.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 78 | 78 | $50,526 | $14,139 | 28.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 55 | 55 | $51,845 | $10,915 | 21.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 157 | 174 | $39,165 | $10,517 | 26.9% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 50 | 50 | $38,398 | $6,257 | 16.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 88 | 88 | $54,161 | $5,271 | 9.7% |
About Dr. Matthew Mcbride, MD
Dr. Matthew Mcbride, MD is a Gastroenterology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871536920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Mcbride, MD has received a total of $83,407 in payments from pharmaceutical and medical device companies, with $789.19 received in 2024. These payments were reported across 466 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($70,033).
As a Medicare-enrolled provider, Mcbride has provided services to 2,533 Medicare beneficiaries, totaling 2,634 services with total Medicare billing of $271,256. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Oklahoma City, OK
- Active Since 06/14/2006
- Last Updated 12/07/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1871536920
Products in Payments
- Humira (Biological) $17,474
- Movantik (Drug) $14,492
- LINZESS (Drug) $9,733
- HUMIRA (Biological) $6,756
- SKYRIZI (Biological) $5,787
- RINVOQ (Biological) $3,784
- ZEPOSIA (Drug) $3,626
- MOVANTIK (Drug) $2,600
- VIBERZI (Drug) $1,459
- STELARA (Biological) $761.41
- INTERSTIM (Device) $329.16
- GATTEX (Drug) $314.40
- XIFAXAN (Drug) $308.62
- Cimzia (Drug) $229.02
- OCA (Drug) $222.00
- INJECTAFER (Drug) $174.40
- INFLECTRA (Biological) $153.86
- CONMED BILIARY (Device) $152.79
- VOQUEZNA (Drug) $146.12
- Olympus Biliary Devices (Device) $138.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oklahoma City
George Salem, Md, MD
Gastroenterology — Payments: $872,730
Tauseef Ali, M.d, M.D
Gastroenterology — Payments: $616,367
Pooja Singhal
Gastroenterology — Payments: $178,683
Dr. Trushar Patel, M.d, M.D
Gastroenterology — Payments: $81,054
Dr. David Stokesberry, M.d, M.D
Gastroenterology — Payments: $41,079
Sanjay Sikka, M.d, M.D
Gastroenterology — Payments: $31,487